Loading...

Immunovia AB (publ)

0G8X.L•LSE
Healthcare
Medical - Diagnostics & Research
£0.46
£-0.01(-1.24%)

Immunovia AB (publ) (0G8X.L) Company Profile & Overview

Explore Immunovia AB (publ)’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Immunovia AB (publ) (0G8X.L) Company Profile & Overview

Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOJeff Borcherding

Contact Information

https://www.immunovia.com
46 4 62 75 60 00
Medicon Village, Lund, 223 63

Company Facts

9 Employees
IPO DateJan 26, 2018
CountrySE
Actively Trading

Frequently Asked Questions

;